top
Search terms
Results 71 - 80 of 119 - ordered by :
Pages: 1 ... 5 6 7 8 9 10 11 ... 12
Ehjcvp

Undoubtedly, one of the most popular scientific activities within the European Society of Cardiology (ESC) is clinical practice guidelines. [...]there are clinical situations that are not included ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, José L. Zamorano

Date : 01/04/2015 Item size : 100514 bytes
Ehjcvp

An index of new research activity in Cardiovascular Pharmacotherapy can be obtained by listing the number of new updates in the 8th edition of Drugs for the Heart2 that covers all the main areas of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Lionel H. Opie

Date : 01/04/2015 Item size : 144582 bytes
Ehjcvp

New oral anticoagulants are used in atrial fibrillation (AF) patients to prevent strokes in the primary and secondary prevention settings.1,2 Since AF are reported to be an independent risk factor ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Shinichi Goto, Shinya Goto

Date : 01/04/2015 Item size : 186244 bytes
Ehjcvp

Furthermore, even the truth changes since we perform new studies and since people challenge the truth When I was in Medical School one professor of Medicine told the class, Damn you if you treat ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/04/2015 Item size : 97793 bytes
Ehjcvp

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery disease Methods and ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, D.G. Kallend, J.A.A. Reijers, S.E. Bellibas, A. Bobillier, H. Kempen, J. Burggraaf, M. Moerland, P.L.J. Wijngaard

Date : 01/01/2016
Ehjcvp

Abstract Aortic valve stenosis (AVS) is associated with significant morbidity and mortality, especially in the presence of symptoms and echocardiographic signs of left ventricular remodelling (i.e. ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Charlotte Andersson, Jawdat Abdulla

Date : 11/09/2016
Ehjcvp

Abstract Aims Therapeutic windows for residual platelet reactivity in patients with coronary artery disease on P2Y12 inhibitors were proposed in a consensus document. Conclusions Our results suggest ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Minka J.A. Vries, Heleen J. Bouman, Renske H. Olie, Leo F. Veenstra, Suzanne Zwaveling, Paul W.M. Verhezen, Arina J. ten ...

Date : 07/09/2016
Ehjcvp

Abstract Aims To determine whether risk factor changes over 6 years were associated with the incidence of atrial fibrillation (AF) among middle-aged men in the Malmö Preventive Project (MPP) ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Linda S.B. Johnson, Tord Juhlin, Gunnar Engström, Peter M. Nilsson

Date : 01/04/2016
Ehjcvp

Significant evidence demonstrated that atherosclerotic plaques are not passive collections of lipids, but sites of active interactions between cells of the immune system and vascular cells that ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Jessica Bullenkamp, Sip Dinkla, Juan Carlos Kaski, Ingrid E. Dumitriu

Date : 01/07/2016
Ehjcvp

Exploring the potential of low-dose sulfasalazine in stable coronary artery disease patients: randomized, double-blind, placebo-controlled study Recent statistics reports by Centre for Disease ...

European Heart Journal - Cardiovascular Pharmacotherapy, CORRESPONDENCE, Kanchan Vohra, Pawan Krishan, Sudhir Varma, Harpreet Singh Kalra

Date : 01/10/2015